Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke [Phase 1]

View source ↗

Summary

Phase 1 exploratory trial evaluating intranasal administration of extracellular vesicles derived from human umbilical cord mesenchymal stem cells for ischemic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (extracellular vesicles derived from human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Ischemic Stroke | Phase 1 | Status: NOT_YET_RECRUITING